US2023051702A1PendingUtilityA1

Compositions for prevention and treatment of symptoms associated with alcohol consumption

62
Assignee: ELIAS MONIRPriority: Feb 22, 2019Filed: Oct 31, 2022Published: Feb 16, 2023
Est. expiryFeb 22, 2039(~12.6 yrs left)· nominal 20-yr term from priority
Inventors:Monir M. Elias
A61K 31/352A61K 31/7034A61K 31/351A61K 31/198A61K 36/33A61K 9/0053A61K 36/67A61K 45/06A61K 9/0019A61K 36/9066A61K 36/28A61K 36/9068A61K 36/906A23L 2/395A61K 31/366A23V 2200/334A23L 2/52
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A composition for mitigating, treating, and/or preventing symptoms associated with veisalgia. In one embodiment the composition comprises one or more ingredients selected from the group consisting of: dihydromyricetin, N-acetyl cysteine, salicin, quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, monk fruit, turmeric, curcumin, ginger root, and black pepper extract. A method for treating symptoms associated with veisalgia is also described. In one embodiment, the composition is administered in liquid or pill form.

Claims

exact text as granted — not AI-modified
I claim: 
     
         1 . A composition comprising dihydromyricetin, N-acetyl cysteine, and salicin. 
     
     
         2 . The composition of  claim 1  further comprising at least one of the ingredients selected from the group consisting of: quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, turmeric, curcumin, milk thistle, monk fruit, hydroxypropyl-beta cyclodextrin, ginger root, and black pepper extract. 
     
     
         3 . The composition of  claim 1 , wherein the composition is integrated into a liquid. 
     
     
         4 . The composition of  claim 1 , wherein the composition is integrated into a capsule, tablet, chewable tablet, or pill. 
     
     
         5 . The composition of  claim 1 , wherein the composition is in powder or liquid form and is readily integratable into food or drink. 
     
     
         6 . A method for treating symptoms associated with veisalgia comprising:
 administering, to a patient, a composition comprising dihydromyricetin, N-acetyl cysteine, and salicin.   
     
     
         7 . The method of  claim 6 , wherein the composition further comprises quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, turmeric, curcumin, milk thistle, monk fruit, hydroxypropyl-beta cyclodextrin, ginger root, or black pepper extract, or a combination thereof. 
     
     
         8 . The method of  claim 6 , wherein the composition is integrated into a liquid. 
     
     
         9 . The method of  claim 6 , wherein the composition is integrated into a capsule, tablet, chewable tablet, or pill. 
     
     
         10 . The method of  claim 6 , wherein the composition is administered via food or drink. 
     
     
         11 . The method of  claim 6 , wherein the composition is administered by injection intravenously, intramuscularly, intrathecally, or subcutaneously; sublingually or buccally; rectally or vaginally; placed in the eye by the ocular route or the ear by the otic route; nasally; inhalation or by nebulization; applied to the skin cutaneous for a local topical or body wide systemic effect; or delivered through the skin by patch transdermally.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.